Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Patrice Wendling

  • News

    Cardiogenic shock teams again tied to lower mortality

    September 23, 2021

    New data suggest centers with a shock team had higher survival and lower resource use in the cardiac ICU.

  • 1
    News

    Two swings, two misses with colchicine, Vascepa in COVID-19

    September 1, 2021

    The study cohorts varied from healthcare and public workers at high risk for infection to individuals already hospitalized with COVID-19.

  • 1
    News

    Dapagliflozin in HFrEF may cut arrhythmias, sudden death: DAPA-HF

    August 27, 2021

    Response to the positive findings was tempered, however, by the post hoc nature of the analysis, choice of primary outcome, and inconsistencies between key subgroups.

  • News

    Reversal agents curb DOAC-related bleeding but deaths still high

    June 17, 2021

    The meta-analysis of more than 4,000 patients also showed thrombotic events were more frequent with andexanet than with 4PCC or idarucizumab.

  • News

    First risk score to predict bleeding risk after TAVR

    June 11, 2021

    PREDICT-TAVR was developed and validated in two national registries in Europe and outperformed existing risk scores developed outside TAVR.

  • 1
    News

    Single subcutaneous shot offers fast, potent platelet inhibition in STEMI

    June 1, 2021

    The effect was seen within 15 minutes of receiving RUC-4, an investigational glycoprotein IIb/IIIa inhibitor, with no thrombocytopenia, in a phase 2a study.

  • 1
    News

    Higher MI shock survival with NCSI protocol: Final results

    April 30, 2021

    Final results of the National Cardiogenic Shock Initiative show better survival rates in acute MI shock than seen in previous North American studies, but 1-year mortality remains a problem.

  • 1
    News

    Arthritis drug may curb myocardial damage in acute STEMI

    April 13, 2021

    Tocilizumab appears to improve myocardial salvage by helping tamp down the inflammatory overshoot that occurs during infarction and reperfusion.

  • 1
    News

    ApoB may better predict mortality risk in statin-treated patients

    March 24, 2021

    In the study, measures of apoB and non-HDL cholesterol, but not LDL cholesterol, were associated with increased residual mortality and myocardial infarction risk.

  • News

    RECOVERY trial of COVID-19 treatments stops colchicine arm

    March 8, 2021

    Recruitment was halted for lack of efficacy in patients hospitalized with the disease.

1 2 3Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
fa-facebookfa-linkedinfa-instagramfa-youtube-playfa-commentfa-envelopefa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences